Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants

Antibody therapies represent a valuable tool to reduce COVID-19 deaths and hospitalizations. Multiple antibody candidates have been granted emergency use authorization by the Food and Drug Administration and many more are in clinical trials. Most antibody therapies for COVID-19 are engineered to bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelhart, Emily, Lopez, Randolph, Emerson, Ryan, Lin, Charles, Shikany, Colleen, Guion, Daniel, Kelley, Mary, Younger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129155/
https://www.ncbi.nlm.nih.gov/pubmed/35769631
http://dx.doi.org/10.1093/abt/tbac011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129155/
https://www.ncbi.nlm.nih.gov/pubmed/35769631
http://dx.doi.org/10.1093/abt/tbac011

Ejemplares similares